Artikel ; Online: Formulation and optimization of a single-layer coat for targeting budesonide pellets to the descending Colon.
Pharmaceutical development and technology
2024 Band 29, Heft 3, Seite(n) 212–220
Abstract: The current budesonide formulations are inadequate for addressing left-sided colitis, and patients might hesitate to use an enema for a prolonged time. This study focuses on developing a single-layer coating for budesonide pellets targeting the ... ...
Abstract | The current budesonide formulations are inadequate for addressing left-sided colitis, and patients might hesitate to use an enema for a prolonged time. This study focuses on developing a single-layer coating for budesonide pellets targeting the descending colon. Pellets containing budesonide (1.5%w/w), PVP K30 (5%w/w), lactose monohydrate (25%w/w) and Avicel pH 102 (68.5%w/w) were prepared using extrusion spheronization technique. Coating formulations were designed using response surface methodology with pH and time-dependent Eudragits. Dissolution tests were conducted at different pH levels (1.2, 6.5, 6.8, and 7.2). Optimal coating formulation, considering coating level and the Eudragit (S + L) ratio to the total coating weight, was determined. Budesonide pellets were coated with the optimized composition and subjected to continuous dissolution testing simulating the gastrointestinal tract. The coating, with 48% S, 12% L, and 40% RS at a 10% coating level, demonstrated superior budesonide delivery to the descending colon. Coated pellets had a spherical shape with a uniform 30 µm thickness coating, exhibiting pH and time-dependent release. Notably, zero-order release kinetics was observed for the last 9 h in colonic conditions. The study suggests that an optimized single-layer coating, incorporating pH and time-dependent polymers, holds promise for consistently delivering budesonide to the descending colon. |
---|---|
Mesh-Begriff(e) | Humans ; Budesonide ; Drug Delivery Systems ; Colon ; Colon, Descending ; Solubility ; Drug Implants ; Polymethacrylic Acids |
Chemische Substanzen | Budesonide (51333-22-3) ; methylmethacrylate-methacrylic acid copolymer (25086-15-1) ; Drug Implants ; Polymethacrylic Acids |
Sprache | Englisch |
Erscheinungsdatum | 2024-03-06 |
Erscheinungsland | England |
Dokumenttyp | Journal Article |
ZDB-ID | 1331774-x |
ISSN | 1097-9867 ; 1083-7450 |
ISSN (online) | 1097-9867 |
ISSN | 1083-7450 |
DOI | 10.1080/10837450.2024.2321250 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Zs.A 5043: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.